EP4326220A1 - Transparente kosmetische zubereitung mit polyglyceryl-6 caprate und polyglyceryl-4 caprate - Google Patents
Transparente kosmetische zubereitung mit polyglyceryl-6 caprate und polyglyceryl-4 caprateInfo
- Publication number
- EP4326220A1 EP4326220A1 EP22716078.5A EP22716078A EP4326220A1 EP 4326220 A1 EP4326220 A1 EP 4326220A1 EP 22716078 A EP22716078 A EP 22716078A EP 4326220 A1 EP4326220 A1 EP 4326220A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- weight
- polyglyceryl
- preparation
- cosmetic preparation
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
Definitions
- the invention belongs to the cosmetic field and relates to an antiperspirant cosmetic preparation which is present as a transparent emulsion.
- cosmetic products are not only used to make people look beautiful and attractive, but with their effect they make a decisive contribution to increased self-esteem and people's well-being. Accordingly, a wide variety of cosmetic products are used for the daily cleansing and care of the skin.
- deodorants and antiperspirants which are used under the armpits to prevent bad smells.
- the cause of bad odors is the decomposition of per se odorless sweat by bacteria. Fatty acid residues occur as a product of the decomposition, which characterize the typically known smell of sweat. Regardless of the fact that deodorants and antiperspirants are used on the same area of skin and have the same objective, they differ in their technical effect.
- Antiperspirants contain antiperspirant active ingredients that serve to impede and reduce the flow of sweat. Aluminum-containing antiperspirant active ingredients clog the sweat glands.
- Deodorants are characterized in that they do not prevent the flow of sweat. Instead, deodorants are products that contain special antimicrobial agents that reduce the growth of bacteria such as Corynebacterium jeikeium or Staphylococcus epidermidis. Consequently, the decomposition of the odorless sweat is reduced, so that less malodor occurs.
- antiperspirants and deodorants are applied to the skin either by means of an application roller or as a spray. Both come as a spray.
- Propellant-operated aerosol sprays as well as pump sprays operated by means of a hand pump are used.
- the composition of the cosmetic preparations varies significantly.
- Antiperspirants which are applied to the skin using an application roller are described, inter alia, in WO2010009880 A1.
- WO2010009880 A1 discloses antiperspirant cosmetic preparations which contain a) aluminum chlorohydrate, b) butylene glycol and/or glycerol, and c) at least one emulsifier. Isocetheth-20 is used as an emulsifier.
- the disclosed formulations containing butylene glycol are transparent.
- a disadvantage is the fact that, in addition to the selection of the polyols, it is crucial for the production of transparent perfume-containing preparations to use emulsifiers which have at least one polyethylene glycol subunit.
- isocetheth-2020 has ethylene glycol units.
- formulations are required which do not contain any such molecules, but it should be ensured that no inhomogeneities occur in the formulation and that the formulations do not become cloudy. In particular, there should be little or no clouding or streaking if the preparations were stored at ⁇ 10° C. or at elevated temperatures, in particular 40° C., for a prolonged period.
- the specific combination of the present invention was able to address this need.
- the preparations of the invention were transparent and homogeneous.
- the present invention relates to a cosmetic preparation in the form of an O/W emulsion containing, based on the total weight of the preparation, a) polyglyceryl-6 caprylates, b) polyglyceryl-4 caprates, c) at least one aluminum-containing antiperspirant active ingredient, and d) butylenes Glycol, characterized in that the preparation contains substances containing at least one polyethylene glycol subunit in proportions of less than 0.5% by weight, preferably less than 0.3% by weight, preferably less than 0.1% by weight and particularly preferably 0% by weight.
- normal conditions / normal conditions refers to 20° C, 1013 hPa and a relative humidity of 50%.
- skin refers exclusively to human skin.
- the preparation according to the invention was surprisingly able to eliminate or reduce the disadvantages of the prior art.
- a polyethylene glycol subunit consists of at least 2 consecutive ethylene glycol units.
- the preparation advantageously contains polyglyceryl-6-caprylate in a proportion of 1 to 10% by weight, further advantageously 1.5 to 8% by weight and particularly advantageously 1.75 to 7% by weight, based on the total weight the preparation.
- the preparation advantageously contains polyglyceryl-4-caprate in a proportion of 1 to 10% by weight, further advantageously 1.5 to 8% by weight and particularly advantageously 1.75 to 7% by weight, based on the total weight the preparation.
- the weight ratio of polyglyceryl-6 caprylate to polyglyceryl-4 caprate is preferably from 1:5 to 5:1, more preferably from 1:4 to 4:1, more preferably from 1:3 to 3:1, more preferably from 1:2 to 2:1, more preferably from 1:1.5 to 1.5:1, more preferably from 1:1.3 to 1.3:1, moreover preferably from 1:1.2 to 1.2:1, further preferably from 1:1.1 to 1.1:1 and particularly preferably from 1:1.05 to 1.05:1.
- the total proportion of polyglyceryl-6 caprylate and polyglyceryl-4 caprate to the total proportion of butylene glycol is from 1:1 to 1:8, preferably from 1:1.1 to 1:6 and particularly preferably from 1:1. 3 to 1:4.5.
- compositions of the present invention contain further emulsifiers, advantageously in proportions of less than 0.5% by weight, preferably less than 0.4% by weight, preferably less than 0.3% by weight, preferably less than 0.2% % by weight, preferably less than 0.1% by weight and particularly preferably 0% by weight, based in each case on the total weight of the preparation.
- the other emulsifiers are selected from the group of emulsifiers which have an HLB value in the range from 10 to 20, preferably from 12 to 18 and particularly preferably from 14 to 17.
- polyglyceryl esters are understood as meaning an ester which is formed from polyglycerol (for example polyglycerol-10) and at least one fatty acid.
- alkyl glucosides include heptyl glucosides, decyl glucosides, lauryl glucosides, caprylyl/caprylic glucosides and coco glucosides.
- One or more other emulsifiers are advantageous, selected from the group of polyglyceryl-3 methylglucose distearate, polyglyceryl-10 caprate, polyglyceryl-10 caprylate, polyglyceryl-10 laurate, polyglyceryl-10 dilaurate, polyglyceryl-10 trilaurate, polyglyceryl-10 myristate, polyglyceryl -10 Dimyristate, Polyglyceryl-10 Oleate, Polyglyceryl-10 Dioleate, Polyglyceryl-10 Stearate, Polyglyceryl-10 Distearate, Polyglyceryl-10 Diisostearate, Polyglyceryl-10 Isostearate, Polyglyceryl-10 Tristearate, Polyglyceryl-6 Dicaprylate, Polygylceryl-6 Tricaprylate, Polyglyceryl -6 Dicaprate, Polyglyceryl-6 Laurate, Polyglyceryl-6 Trilaurate, Polyglyceryl-6 Oleate, Poly
- the one or more other emulsifiers selected from the group of polyglyceryl-10 caprates, polyglyceryl-10 caprylates, polyglyceryl-10 laurates, polyglyceryl-10 dilaurates, polyglyceryl-10 myristates, polyglyceryl-10 dimyristates, polyglyceryl-10 oleates, polyglyceryl- 10 Dioleates, Polyglyceryl-10 Stearate, Polyglyceryl-10 Isosteareate, Polyglyceryl-6 Laurate, Polyglyceryl-6 Ricinoleate, Polyglyceryl-6 Stearate, Polyglyceryl-5 Laurate, Polyglyceryl-5 Myristate, Polyglyceryl-5 Oleate, Polyglyceryl-5 Dioleate, Polyglyceryl- 5 stearates, polyglyceryl-3 caprates/caprylates/succinates, polyglyceryl-3 cocoates, polyglyceryl-3 laurates
- the preparation contains at least one aluminum-containing antiperspirant active ingredient.
- Examples of aluminum salts according to the invention are:
- Aluminum salts such as aluminum chloride AlCb, aluminum sulfate Al 2 (S0 4 ) 3
- At least one aluminum zirconium salt is present as the antiperspirant active ingredient.
- These are advantageously selected from the group of aluminium/zirconium trichlorohydrex glycine ([ALZr(OH)i3Cl3] x H2O x Gly), aluminium/zirconium tetrachlorohydrex glycine ([ALZr(OH)i2CL] x H2O x Gly), aluminium/zirconium pentachlorohydrex glycine ([AlsZr(OH)23Cl5] x H2O x Gly), aluminum/zirconium octachlorohydrex glycine ([Al8Zr(OH)2oCls] x H2O x Gly) and the glycine free aluminium/zirconium salts.
- Aluminum/zirconium tetrachlorohydrex glycine is particularly preferred.
- aluminum chlorohydrate aluminum sesquichlorohydrate and/or aluminum/zirconium tetrachlorohydrex glycine are present as the aluminum-containing antiperspirant active ingredient, with aluminum chlorohydrate being the most preferred.
- the total proportion of aluminum-containing antiperspirant active ingredients is advantageously from 1% by weight to 30% by weight, preferably from 2% by weight to 25% by weight and particularly preferably from 5% by weight to 22% by weight on the total weight of the preparation.
- the proportion of aluminum chlorohydrate is from 1% by weight to 30% by weight, preferably from 2% by weight to 25% by weight and particularly preferably from 5% by weight to 22% by weight. %, based on the total weight of the preparation.
- the preparation contains butylene glycol (butylene glycol).
- the proportion of butylene glycol is advantageously from 1 to 40% by weight, preferably from 2 to 30% by weight and particularly preferably from 4 to 25% by weight, based on the total weight of the preparation.
- the preparation additionally contains at least one or more perfume substances which are liquid under normal conditions.
- perfumes are selected from essential oils, geraniol, geranyl acetate, linalool, linalyl acetate, tetrahydrolinalool, citronellol, citronellyl acetate, dihydromyrcenol, dihydromyrcenyl acetate, tetrahydromyrcenol, terpineol, terpinyl acetate, nopol, nopyl acetate, 2-phenyl benzyl alcohol, benzyl acetate, benzyl salicylate, benzyl benzoate, styrallyl acetate, Amyl salicylate, dimethyl benzyl carbinol, trichloromethylphenyl carbinyl acetate, p-tert-butylcyclohexyl acetate, isononyl
- the proportion of perfume substances which are liquid under normal conditions is advantageously from 0.001 to 2% by weight, preferably from 0.005 to 1.5% by weight and particularly preferably from 0.01 to 1.4% by weight, based on the total weight of the preparation .
- the preparation contains further polyols in proportions of less than 0.5% by weight, preferably less than 0.4% by weight, preferably less than 0.3% by weight, preferably less than 0 2% by weight, preferably less than 0.1% by weight and particularly preferably 0% by weight, based in each case on the total weight of the preparation.
- the preparation contains further propanediol, glycerol and/or pentylene glycol in total proportions of less than 0.5% by weight, preferably less than 0.4% by weight, preferably less than 0.3% by weight. %, preferably less than 0.2% by weight, preferably less than 0.1% by weight and particularly preferably 0% by weight, based in each case on the total weight of the preparation.
- the preparation contains water, it being preferred if the proportion of water is from 40 to 90% by weight, particularly preferably from 45 to 80% by weight, the figures relating to the total weight of the preparation relate.
- the preparation according to the invention contains no other polyols having 2 to 4 carbon atoms.
- the preparations can contain further excipients.
- These can include dyes, thickeners, deodorants or other ingredients.
- this has a transmission of at least 80% at 880 nm.
- the measurement is carried out with a Turbiscan Lab Expert Analyzer according to the principle of multiple light scattering at 30.5°C.
- Backscatter is detected at a 45° scattering angle in relation to the incident light beam at 0°
- transmission is detected at a 180° scattering angle in relation to the incident light beam at 0°.
- the measurement of backscatter and transmission is height-resolved, the resolution in the Turbiscan lab is 40pm.
- the device was calibrated with standard cells filled with silicone oil and made of Teflon. Preparations with less than 80% transmission are described as translucent or cloudy.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102021203833.6A DE102021203833A1 (de) | 2021-04-19 | 2021-04-19 | Transparente kosmetische Zubereitung mit Polyglyceryl-6 Caprate und Polyglyceryl-4 Caprate |
| PCT/EP2022/057449 WO2022223219A1 (de) | 2021-04-19 | 2022-03-22 | Transparente kosmetische zubereitung mit polyglyceryl-6 caprate und polyglyceryl-4 caprate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4326220A1 true EP4326220A1 (de) | 2024-02-28 |
Family
ID=81307003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP22716078.5A Pending EP4326220A1 (de) | 2021-04-19 | 2022-03-22 | Transparente kosmetische zubereitung mit polyglyceryl-6 caprate und polyglyceryl-4 caprate |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4326220A1 (de) |
| DE (1) | DE102021203833A1 (de) |
| WO (1) | WO2022223219A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230346681A1 (en) * | 2022-04-28 | 2023-11-02 | L'oreal | Compositions comprising a polyphenol and a glycerolated compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008034957B4 (de) | 2008-07-25 | 2011-12-22 | Beiersdorf Ag | Ölmigrationsinhibitiertes Produkt |
| EP3168251B1 (de) * | 2015-11-16 | 2019-02-06 | Evonik Degussa GmbH | Vernetzte polyglycerinester |
| DE102020214349A1 (de) * | 2020-11-16 | 2022-05-19 | Beiersdorf Aktiengesellschaft | Pumpspray mit Aluminiumsalzen |
-
2021
- 2021-04-19 DE DE102021203833.6A patent/DE102021203833A1/de active Pending
-
2022
- 2022-03-22 WO PCT/EP2022/057449 patent/WO2022223219A1/de not_active Ceased
- 2022-03-22 EP EP22716078.5A patent/EP4326220A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE102021203833A1 (de) | 2022-10-20 |
| WO2022223219A1 (de) | 2022-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69928378T2 (de) | Geruchsverstärkende zusammensetzung für kosmetische produkte | |
| EP4243760A1 (de) | Pumpspray mit aluminiumsalzen | |
| EP3122316A1 (de) | Öl in wasser-emulsionen mit einem gehalt an 4-hydroxyacetophenon und anionischen emulgatoren | |
| EP4326221A1 (de) | Transparente kosmetische zubereitung | |
| WO2022223219A1 (de) | Transparente kosmetische zubereitung mit polyglyceryl-6 caprate und polyglyceryl-4 caprate | |
| DE102010034389B4 (de) | Stabilisierte W/O-Emulsionen | |
| WO2024083394A1 (de) | Transparente kosmetische zubereitung mit polyglyceryl-3 caprate/caprylate/succinate | |
| EP4326219A1 (de) | Transparente kosmetische zubereitung | |
| WO2024083395A1 (de) | Transparentes kosmetisches produkt | |
| DE102024205630A1 (de) | Antitranspirantien mit Benzaldehyd und Ionone | |
| WO2025261645A1 (de) | Verminderte textilverfleckung von antitranspirantien | |
| DE102020214353A1 (de) | Emulsion enthaltend Ceratonia Siliqua Gum und Aluminium Chlorohydrate | |
| EP4243761A1 (de) | Pumpspray mit deowirkern | |
| DE202010011395U1 (de) | Stabilisierte W/O-Emulsionen | |
| DE102020214364A1 (de) | Emulsion enthaltend Biopolymere und Aluminium Chlorohydrate | |
| WO2026021726A1 (de) | Selektives deodorant mit propandiol caprylate | |
| WO2026021725A1 (de) | Wirkstoffkombination gegen das bakterium staphylococcus hominis und in deodorant- und/oder antitranspirantzubereitung | |
| DE102023205451A1 (de) | Xanthangummi enthaltende kosmetische Zubereitung mit Acetaten | |
| DE102023205456A1 (de) | Xanthangummi enthaltende kosmetische Zubereitung mit Benzylacetaten | |
| DE102023205708A1 (de) | Xanthangummi enthaltende kosmetische Zubereitung mit Benzaldehyd | |
| EP4288018A1 (de) | Antitranspirantsprays mit geringerer textilverfleckung | |
| WO2019120664A1 (de) | Topische zubereitung zur verbesserung der hautfeuchtigkeit | |
| EP3036010A1 (de) | Sterolester in deodorant- und/oder antiperspirantzubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20231120 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20250512 |